| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 08/28/2012 | CA2604351C Polynucleotides and methods for making plants resistant to fungal pathogens |
| 08/28/2012 | CA2513073C Method for determining the amount of template nucleic acid present in a sample |
| 08/28/2012 | CA2493918C Method and reagent system with non-regenerable enzyme-coenzyme complex |
| 08/28/2012 | CA2479414C Inhibition of the .beta.3 subunit of l-type ca2+ channels |
| 08/28/2012 | CA2467383C Rapidly maturing fluorescent proteins and methods for using the same |
| 08/28/2012 | CA2454073C Mutations in ion channels |
| 08/28/2012 | CA2450470C Method for rapid screening of bacterial transformants and novel simian adenovirus proteins |
| 08/28/2012 | CA2445578C Biological pacemaker comprising dominant-negative kir2.1aaa |
| 08/28/2012 | CA2407240C Method for obtaining plants exhibiting enhanced resistance to water stress |
| 08/28/2012 | CA2402352C Fluorescent membrane intercalating probes and methods for their use |
| 08/28/2012 | CA2398590C Cells for drug discovery |
| 08/28/2012 | CA2387805C Nucleic acids encoding endotheliases, endotheliases and uses thereof |
| 08/28/2012 | CA2383880C Methods and compositions for detecting pathological events |
| 08/28/2012 | CA2284110C An ex vivo animal or challenge model as method to measure protective immunity directed against parasites and vaccines shown to be protective in said method |
| 08/25/2012 | CA2733021A1 Cleavage kit, and gene therapy by using the same and nucleic acid cleavage detection apparatus |
| 08/23/2012 | WO2012112970A2 Methods and compositions for detecting genetic material |
| 08/23/2012 | WO2012112955A2 Methods for identifying subjects with a genetic risk for developing iga nephropathy |
| 08/23/2012 | WO2012112911A2 Devices and methods for optical pathology |
| 08/23/2012 | WO2012112906A1 Cancer screening by detection of ultrastructural and molecular markers |
| 08/23/2012 | WO2012112884A2 Real-time pcr point mutation assays for detecting hiv - 1 resistance to antiviral drugs |
| 08/23/2012 | WO2012112883A1 The kras-variant and endometriosis |
| 08/23/2012 | WO2012112846A2 Systems and methods for diagnosing a predisposition to develop cancer |
| 08/23/2012 | WO2012112720A2 Methods for predicting cardiovascular risks and responsiveness to statin therapy using snps |
| 08/23/2012 | WO2012112714A1 Improved methods to detect and quantify rna |
| 08/23/2012 | WO2012112606A1 Detecting methylati0n in a subpopulation of genomic dna |
| 08/23/2012 | WO2012112582A2 Polynucleotide primers and probes |
| 08/23/2012 | WO2012112563A2 Methods and compositions for the target-localized anchoring of detectable label |
| 08/23/2012 | WO2012112315A2 Methods for diagnosis of kawasaki disease |
| 08/23/2012 | WO2012112245A1 Modulation of phosphatidylinositol-5-phosphate-4-kinase activity |
| 08/23/2012 | WO2012112012A2 Simultaneous diagnosis kit for a disease due to a respiratory virus |
| 08/23/2012 | WO2012111881A1 Parent strain of novel white flammulina velutipes |
| 08/23/2012 | WO2012111842A1 Amyloid protein oligomer binding aptamer |
| 08/23/2012 | WO2012111818A1 Fluorescent probe |
| 08/23/2012 | WO2012111366A1 Analyzer |
| 08/23/2012 | WO2012111249A1 Method for detecting mass change in mass spectrometry method and method for quantifying absolute amount of stable isotope-labeled protein |
| 08/23/2012 | WO2012110999A1 Genetic markers for prognosis of rheumatoid arthritis treatment efficacy |
| 08/23/2012 | WO2012110899A2 Method for localizedin situdetection of mrna |
| 08/23/2012 | WO2012110822A1 Method for identifying neonates at risk for necrotizing enterocolitis |
| 08/23/2012 | WO2012110793A2 Cd4+ t-cell gene signature for rheumatoid arthritis (ra) |
| 08/23/2012 | WO2012110789A1 Method for assaying ogfod1 activity |
| 08/23/2012 | WO2012110641A1 Cell culture method and system for establishing an in vitro model of the intestinal barrier |
| 08/23/2012 | WO2012110620A1 Screening of constitutional mismatch repair-deficiency (cmmr-d) |
| 08/23/2012 | WO2012109963A1 Rna cleaving agent and use thereof |
| 08/23/2012 | WO2012109752A1 Steroid alkaloids and uses thereof as antimicrobial agents against electron transport-deficient microbes and as potentiators for antimicrobial agents against pathogenic bacteria |
| 08/23/2012 | WO2012092181A3 Articles and method for detecting a target microorganism |
| 08/23/2012 | WO2012083189A3 Methods, compositions, systems, apparatuses and kits for nucleic acid amplification |
| 08/23/2012 | WO2012081928A3 Method for detecting methylation of the bowel-cancer-specific methylation marker gpm6a gene in order to diagnose bowel cancer |
| 08/23/2012 | WO2012079010A3 Improved method and kit for determining severity and progression of periodontal disease |
| 08/23/2012 | WO2012078752A8 Serine protease inhibitor kazal antibodies |
| 08/23/2012 | WO2012071471A3 Biosensing systems for measurement of lactose |
| 08/23/2012 | WO2012070776A9 Method for analyzing and predicting risk of hepatocellular carcinoma in patients with chronic hepatitis b |
| 08/23/2012 | WO2012069941A3 Vaginal indicator to detect biomarkers of good health |
| 08/23/2012 | WO2012067450A3 Efemp1 gene as a diagnostic marker for prostate cancer |
| 08/23/2012 | WO2012061719A3 Dna origami devices |
| 08/23/2012 | WO2012061227A3 Biological sterilization indicator |
| 08/23/2012 | WO2012054873A3 Varietal counting of nucleic acids for obtaining genomic copy number information |
| 08/23/2012 | WO2012040226A3 Gene expression in n-cadherin overexpressing prostate cancers and their controls |
| 08/23/2012 | WO2012024513A3 Molecular detection of xmrv infection |
| 08/23/2012 | WO2012007931A3 Silver electrode catalyst |
| 08/23/2012 | WO2011143656A3 Compositions and methods of identifying tumor specific neoantigens |
| 08/23/2012 | WO2011122857A3 Composition for predicting prognosis of breast cancer, and kit containing same |
| 08/23/2012 | US20120216320 Method for modulating plant growth, nucleic acid molecules and polypeptides encoded thereof useful as modulating agent |
| 08/23/2012 | US20120216317 Nucleotide sequences and polypeptides encoded thereby useful for increasing plant size and increasing the number and size of leaves |
| 08/23/2012 | US20120216313 Spinach line sp6504 |
| 08/23/2012 | US20120216304 Humanized animals via tissue engineering and uses thereof |
| 08/23/2012 | US20120216303 Novel therapeutic uses of human formyl peptide receptor antagonists |
| 08/23/2012 | US20120215514 Systems and methods for detecting biological features |
| 08/23/2012 | US20120215460 Temperature-Adjusted Analyte Determination For Biosensor Systems |
| 08/23/2012 | US20120215457 Methods and systems to analyze reactions using an information system |
| 08/23/2012 | US20120214951 Preparation of polyphosphazene microspheres |
| 08/23/2012 | US20120214880 Cancer screening by detection of ultrastructural and molecular markers |
| 08/23/2012 | US20120214868 Modified L-Nucleic Acid |
| 08/23/2012 | US20120214866 Treatment with cytokines |
| 08/23/2012 | US20120214865 Methods for slowing familial als disease progression |
| 08/23/2012 | US20120214864 Mirnas dysregulated in triple-negative breast cancer |
| 08/23/2012 | US20120214860 Method of regulating the expression level of survival of motor neuron 1 (smn1) and detecting enzyme activity of ubiquitin carboxyl-terminal hydrolase l1 (uchl1) |
| 08/23/2012 | US20120214829 Molecular Predictors of Therapeutic Response to Specific Anti-Cancer Agents |
| 08/23/2012 | US20120214828 Determining sensitivity of cells to b-raf inhibitor treatment by detecting kras mutation and rtk expression levels |
| 08/23/2012 | US20120214748 Novel peptides, process for preparation thereof, and use thereof |
| 08/23/2012 | US20120214737 Methods for protecting dopaminergic neurons from stress and promoting proliferation and differentiation of oligodendrocyte progenitors by nrg-2 |
| 08/23/2012 | US20120214705 Beta-defensin 2 genetic variation predicts h. pylori susceptibility |
| 08/23/2012 | US20120214685 Methods and compositions for diagnosis of ectopic pregnancy |
| 08/23/2012 | US20120214684 Compositions and methods for detecting and treating prostate carcinoma |
| 08/23/2012 | US20120214682 Microrna signatures indicative of immunomodulating therapy for multiple sclerosis |
| 08/23/2012 | US20120214681 Multiplexed Analysis Of Polymorphic Loci By Concurrent Interrogation And Enzyme-Medicated Detection |
| 08/23/2012 | US20120214677 Luciferase biosensor |
| 08/23/2012 | US20120214192 Method for Producing Antigen-specific B Cell Population |
| 08/23/2012 | US20120214191 Methods and Systems for Efficient Processing of Biological Samples |
| 08/23/2012 | US20120214190 System and method based on blood components for estimating human physiological parameters |
| 08/23/2012 | US20120214189 Devices and Methods for Pharmacokinetic-Based Cell Culture System |
| 08/23/2012 | US20120214188 Light-activated ion channel molecules and uses thereof |
| 08/23/2012 | US20120214186 METHODS AND COMPOSITIONS FOR DETECTING AND QUANTIFYING sAPPbeta |
| 08/23/2012 | US20120214181 Assay for pcsk9 inhibitors |
| 08/23/2012 | US20120214174 Gene and polypeptide relating to breast cancer |
| 08/23/2012 | US20120214171 Rotation-dependent transcriptional sequencing systems and methods of using |
| 08/23/2012 | US20120214170 Cellular depletion of biomolecular targets |
| 08/23/2012 | US20120214169 Differential levels of haptoglodin isoforms in small cell lung cancer |
| 08/23/2012 | US20120214167 Apparatus for bio-automation |
| 08/23/2012 | US20120214166 Probe for Detecting Polymorphism in EGFR Gene and Use of the Probe |
| 08/23/2012 | US20120214165 Methods and Compositions for the Diagnosis and Treatment of Thyroid Cancer |